Description

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic research peptide classified as a growth hormone secretagogue. It is designed to stimulate the pituitary gland by interacting with growth hormone–releasing hormone (GHRH) receptors, promoting increased endogenous growth hormone release. The attached DAC allows the peptide to bind to albumin, significantly extending its stability and activity duration. Because of this prolonged effect, CJC-1295 with DAC is commonly used in research examining sustained growth hormone signaling, IGF-1 pathways, metabolic regulation, and systemic recovery processes.